Stay updated on TATE-PD1 Combo in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.

Latest updates to the TATE-PD1 Combo in Liver Cancer Clinical Trial page
- Check6 days agoChange DetectedAdded a Locations section listing California, Oklahoma, and Wisconsin; removed the HHS Vulnerability Disclosure link; updated revision to v3.3.3.SummaryDifference0.4%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision label updated from v3.3.1 to v3.3.2. No study content or critical page elements appear to be altered.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision: v3.3.1 is displayed on the page, replacing v3.2.0. No study content or essential details appear to have changed.SummaryDifference0.1%

- Check42 days agoChange DetectedThe government funding notice previously displayed on the page has been removed. This change does not affect the study details, eligibility criteria, or trial operations; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedThe changes appear to be minor visual/layout updates across the page with no changes to core study details, eligibility criteria, locations, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check85 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference4%

Stay in the know with updates to TATE-PD1 Combo in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TATE-PD1 Combo in Liver Cancer Clinical Trial page.